Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

BACKGROUND. Conflicting data exist regarding the prognostic impact of the isocitrate dehydrogenase (IDH) mutation in intrahepatic cholangiocarcinoma (ICC), and limited data exist in patients with advanced-stage disease. Similarly, the clinical phenotype of patients with advanced IDH mutant (IDHm) IC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Goyal, Lipika, Govindan, Aparna, Sheth, Rahul A., Nardi, Valentina, Blaszkowsky, Lawrence S., Faris, Jason E., Clark, Jeffrey W., Ryan, David P., Kwak, Eunice L., Allen, Jill N., Murphy, Janet E., Saha, Supriya K., Hong, Theodore S., Wo, Jennifer Y., Ferrone, Cristina R., Tanabe, Kenneth K., Chong, Dawn Q., Deshpande, Vikram, Borger, Darrell R., Iafrate, A. John, Bardeesy, Nabeel, Zheng, Hui, Zhu, Andrew X.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2015
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571807/
https://ncbi.nlm.nih.gov/pubmed/26245674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados